Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 821 | 20,272 | 0 | 1,935 | 112,089 |
| Gross Profit | 821 | 20,272 | N/A | 1,935 | 112,089 |
| Operating Expenses | 34,343 | 21,396 | 30,876 | 25,496 | 33,799 |
| Operating Income | -33,522 | -1,124 | -30,876 | -23,561 | 78,290 |
| Other Income | 140 | 111 | 131 | 260 | 364 |
| Pre-tax Income | -33,382 | -1,013 | -30,745 | -23,301 | 78,654 |
| Income Tax | N/A | N/A | N/A | N/A | -255 |
| Net Income Continuous | -33,382 | -1,013 | -30,745 | -23,301 | 78,909 |
| Net Income | $-33,382 | $-1,013 | $-30,745 | $-23,301 | $78,909 |
| EPS Basic Total Ops | -23.05 | -0.72 | -21.97 | -16.93 | 60.87 |
| EPS Basic Continuous Ops | -23.14 | -0.73 | -22.12 | -16.81 | 60.66 |
| EPS Diluted Total Ops | -23.05 | -0.72 | -21.97 | -16.93 | 60.87 |
| EPS Diluted Continuous Ops | -23.14 | -0.73 | -22.12 | -16.81 | 60.59 |
| EBITDA(a) | $-32,852 | $-525 | $-30,303 | $-22,988 | $78,788 |